24/7 Clients Support
- 24/7
Customer Service
- ISO 9001
Certification Company
- WHO-GMP
Certified Company
SORALIEVA 200MG is an Tablet medication used for treatment purposes. It is manufactured by Allieva Pharma Private Limited.
| Brand Name | SORALIEVA 200MG |
|---|---|
| Composition | Sorafenib Tablets 200mg |
| Manufacturer | Allieva Pharma Private Limited |
| Dosage Form | Tablet |
| Packaging | Btl (30 tab) |
| Country of Origin | India |
Sorafenib Tablets IP 200mg (Sorafenib Tablets 200mg) is a widely used Tablet medicine manufactured by Allieva Pharma Private Limited. It is commonly prescribed for...
SORALIEVA contains Sorafenib, an oral multi-kinase inhibitor. It blocks multiple kinases involved in tumor cell proliferation and angiogenesis, including RAF kinases, VEGFR, and PDGFR, slowing tumor growth.
Sorafenib is used for:
1. Hepatocellular carcinoma (HCC) – unresectable or advanced
2. Renal cell carcinoma (RCC) – advanced or metastatic
3. Differentiated thyroid carcinoma – radioactive iodine-refractor
Common side effects:
• Hand–foot skin reaction (redness, pain, peeling)
• Diarrhea
• Fatigue
• Hair thinning or hair loss
• Hypertension
• Loss of appetite
Serious side effects:
• Severe bleeding
• Liver toxicity
• Cardiac events
• Gastrointestinal perforation (rare)
• Severe infections
• Standard dose: 400 mg orally twice daily (can be adjusted based on tolerance)
• Take on an empty stomach (at least 1 hour before or 2 hours after food)
• Dose modification may be required in hepatic impairment or side effects
NOTE: This medicine should be taken only under a doctor’s supervision.